Login:
 
Thompson J. Mortality risk raised during induction with methadone in opioid substitution therapy. Practitioner Nov 2017;261(1809):8-11

Mortality risk raised during induction with methadone in opioid substitution therapy

23 Nov 2017Pais-up subscribers

Patients undergoing opioid substitution treatment have an increased mortality risk during the induction phase with methadone but not with buprenorphine, a meta-analysis has found. Mortality risk is also raised in the period immediately after leaving treatment with both drugs.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article